CONGEN is an innovative biotechnology company. We want to use our products and services to help improve the health of people and animals and achieve commercial success at the same time. Our core activity is the development, validation and commercialisation of molecular biological detection methods and our core competency is real-time PCR procedures.
CONGEN products address a huge range of clinical and food diagnostic issues. Our aim is the rapid implementation of current scientific and technological developments and the latest requirements by creating fast, simple and safe products that optimally meet the demands of our global customers.
Our core competencies include the design and validation of multiplex real-time PCR procedures. CONGEN is among the world leader in this field.
The goal of this method is to enable the detection of increasing numbers of targets using PCR methods within a single reaction vessel. Reliable multiplex detection methods allows clients to answer questions faster, simpler and more efficiently.
The solutions we develop are motivated either by clearly defined demands by our clients or by analytical problems that remain unsolved.
We work with a network of partners from the research and industry sectors in order to find innovative solutions with product advantages over the state of the art.
Are you interested in working together with us to develop new strategies for detection according to your own specifications? Are you planning a new research project and looking for a competent partner? Contact us to discuss the possibilities.